PULMONARY TUBERCULOSIS
Clinical trials for PULMONARY TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new PULMONARY TUBERCULOSIS trials appear
Sign up with your email to follow new studies for PULMONARY TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race for better TB treatment: new drug combos enter human trials
Disease control Recruiting nowThis study is testing new combinations of tuberculosis drugs to see if they work better and are safer than the current standard treatment. It will enroll 315 adults with drug-susceptible lung TB to compare experimental regimens against the usual four-drug therapy. The main goal i…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Old heart drug could be new weapon against World's deadliest infection
Disease control Recruiting nowThis study is testing if adding atorvastatin, a common cholesterol-lowering drug, to the standard tuberculosis (TB) treatment helps patients get better faster and more completely. It will involve 440 people with active lung TB to see if the combination clears the infection from t…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: Obafemi Awolowo University Teaching Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Breakthrough trial aims to slash TB treatment time in half
Disease control Recruiting nowThis large, Phase 3 trial is testing a new, shorter combination of drugs to treat all types of active lung tuberculosis, including drug-resistant strains. The goal is to see if this 'pan-TB' regimen can safely cut treatment time from the current 4-6 months down to just 2-3 months…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE3 • Sponsor: Shenzhen Third People's Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Race to slash TB treatment time in half
Disease control Recruiting nowThis large international trial aims to find faster, safer treatments for tuberculosis (TB). It will test 11 new drug combinations, including two promising new drugs, on up to 2,500 adults with lung TB. The goal is to shorten the standard 6-month treatment to as little as 2 months…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Breakthrough trial aims to cut Drug-Resistant TB treatment in half
Disease control Recruiting nowThis study is testing whether adding a new drug called quabodepistat to existing tuberculosis medications can shorten treatment for drug-resistant TB. Researchers want to see if a 4-month treatment works as well as the current 6-month standard, while also being safer. The trial w…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Scientists test faster, safer tuberculosis treatments
Disease control Recruiting nowThis study aims to find better drug combinations to treat drug-sensitive lung tuberculosis. It will test several new and optimized treatment regimens against the current standard treatment in adults with newly diagnosed TB. The goal is to find treatments that work faster, are saf…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: Michael Hoelscher • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC